|
KR101520534B1
(ko)
|
2012-05-07 |
2015-05-21 |
고려대학교 산학협력단 |
말초혈액단핵구 유래 자연 살해세포의 유도 및 증식 방법
|
|
AU2013204922B2
(en)
|
2012-12-20 |
2015-05-14 |
Celgene Corporation |
Chimeric antigen receptors
|
|
EP2934532B1
(en)
|
2012-12-20 |
2019-10-23 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
EP2970372B1
(en)
|
2013-03-15 |
2020-09-30 |
Celgene Corporation |
Modified t lymphocytes
|
|
EP3805371A1
(en)
|
2014-05-15 |
2021-04-14 |
National University of Singapore |
Modified natural killer cells and uses thereof
|
|
AU2015305449B2
(en)
*
|
2014-08-22 |
2021-05-06 |
Celgene Corporation |
Methods of treating multiple myeloma with immunomodulatory compounds in combination with antibodies
|
|
WO2016089826A1
(en)
|
2014-12-01 |
2016-06-09 |
Summa Health |
Camkk1 as a novel regenerative therapeutic
|
|
US10034901B2
(en)
|
2015-01-22 |
2018-07-31 |
University Of Massachusetts |
Cancer immunotherapy
|
|
DK3303394T3
(da)
|
2015-05-29 |
2020-07-06 |
Agenus Inc |
Anti-ctla-4-antistoffer og fremgangsmåder til anvendelse deraf
|
|
US12590321B2
(en)
|
2016-03-19 |
2026-03-31 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying and expanding lymphocytes and regulating the activity thereof
|
|
WO2021178701A1
(en)
*
|
2020-03-05 |
2021-09-10 |
Exuma Biotech Corp. |
Methods and compositions for the delivery of modified lymphocyte aggregates
|
|
US11111505B2
(en)
|
2016-03-19 |
2021-09-07 |
Exuma Biotech, Corp. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
|
US11325948B2
(en)
|
2016-03-19 |
2022-05-10 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL
|
|
CA3019835A1
(en)
|
2016-04-08 |
2017-10-12 |
Purdue Research Foundation |
Methods and compositions for car t cell therapy
|
|
EP4650005A3
(en)
|
2016-07-15 |
2026-01-28 |
Viracta Subsidiary, Inc. |
Histone deacetylase inhibitors for use in immunotherapy
|
|
KR20230133934A
(ko)
|
2016-10-11 |
2023-09-19 |
아게누스 인코포레이티드 |
항-lag-3 항체 및 이의 사용 방법
|
|
WO2018081817A2
(en)
*
|
2016-10-31 |
2018-05-03 |
University Of Massachusetts |
Targeting microrna-101-3p in cancer therapy
|
|
IL307242B1
(en)
|
2016-12-07 |
2026-07-01 |
Agenus Inc |
Anti-CTLA-4 antibodies and methods of using them
|
|
CN110300599B
(zh)
|
2016-12-07 |
2024-07-02 |
艾吉纳斯公司 |
抗体和其使用方法
|
|
EP3581190B1
(en)
*
|
2016-12-09 |
2021-03-10 |
ONK Therapeutics Limited |
Engineered natural killer cells and uses thereof
|
|
CN108277205B
(zh)
*
|
2016-12-30 |
2022-12-20 |
四川大学 |
表达cxcr4的嵌合抗原受体修饰的淋巴细胞及制备方法和用途
|
|
CN110582288B
(zh)
|
2017-02-28 |
2024-09-20 |
恩多塞特公司 |
用于car t细胞疗法的组合物和方法
|
|
CN117363636A
(zh)
|
2017-03-27 |
2024-01-09 |
新加坡国立大学 |
一种编码嵌合受体的多核苷酸
|
|
MX2019011570A
(es)
|
2017-03-27 |
2019-11-18 |
Nat Univ Singapore |
Lineas celulares estimuladoras para expansion y activacion ex vivo de celulas asesinas naturales.
|
|
US12129487B2
(en)
*
|
2017-03-27 |
2024-10-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method to obtain lymphoid progenitors
|
|
CA3064897A1
(en)
|
2017-05-25 |
2018-11-29 |
University Of Central Florida Research Foundation, Inc. |
Novel oncolytic viruses for sensitizing tumor cells to killing by natural killer cells
|
|
TWI676483B
(zh)
*
|
2017-08-06 |
2019-11-11 |
強普生技股份有限公司 |
醫藥套組及其用途
|
|
WO2019067792A1
(en)
*
|
2017-09-28 |
2019-04-04 |
Celularity, Inc. |
TUMOR CONTROL WITH INTERMEDIATE NATURAL KILLER CELLS DERIVED FROM HUMAN PLACENTA (PINK) IN COMBINATION WITH ANTIBODY
|
|
EP3691660A4
(en)
|
2017-10-02 |
2021-07-07 |
Gamida-Cell Ltd. |
EXPANSION AND USE OF EXPANDED NK CELL FRACTIONS
|
|
KR20200076732A
(ko)
*
|
2017-11-03 |
2020-06-29 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
Cd38-지시된 키메라 항원 수용체 작제물
|
|
US11795226B2
(en)
|
2017-12-12 |
2023-10-24 |
Macrogenics, Inc. |
Bispecific CD16-binding molecules and their use in the treatment of disease
|
|
CN108060137B
(zh)
*
|
2017-12-26 |
2021-07-02 |
博生吉医药科技(苏州)有限公司 |
Il7和il21修饰的nk92细胞、制备方法及其应用
|
|
WO2019127215A1
(en)
*
|
2017-12-28 |
2019-07-04 |
Nanjing Legend Biotech Co., Ltd. |
Multispecific chimeric receptors comprising an nkg2d domain and methods of use thereof
|
|
TR201900059A2
(tr)
*
|
2018-01-05 |
2019-07-22 |
Gnt Biotech & Medicals Corp |
Bi̇r farmasöti̇k kombi̇nasyon ve tümör mi̇kroortaminin ve i̇mmünoterapi̇ni̇n regülasyonu i̇çi̇n yöntem
|
|
WO2019144095A1
(en)
|
2018-01-22 |
2019-07-25 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Methods of use for car t cells
|
|
CA3089562A1
(en)
|
2018-01-30 |
2019-08-08 |
University Of Massachusetts |
Methods of treating a wound using epigenetic regulation
|
|
CN115710576A
(zh)
|
2018-02-01 |
2023-02-24 |
Nkmax有限公司 |
产生天然杀伤细胞的方法和用于治疗癌症的组合物
|
|
JP7360174B2
(ja)
|
2018-02-09 |
2023-10-12 |
ナショナル ユニヴァーシティー オブ シンガポール |
ナチュラルキラー細胞免疫療法における活性化キメラ受容体及びその使用
|
|
WO2019165121A1
(en)
|
2018-02-21 |
2019-08-29 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses therof
|
|
JP7568224B2
(ja)
|
2018-02-23 |
2024-10-16 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞療法のための配列決定法
|
|
US20190284288A1
(en)
*
|
2018-03-19 |
2019-09-19 |
The Regents Of The University Of Michigan |
Compositions and methods for t-cell and cytokine activation
|
|
US12441787B2
(en)
|
2018-04-02 |
2025-10-14 |
National University Of Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
EP3781182A4
(en)
|
2018-04-18 |
2021-11-17 |
Summa Health |
COMPOSITIONS AND METHODS OF TREATMENT OF ISCHEMIA AND CARDIOMYOPATHIA
|
|
WO2019200586A1
(en)
*
|
2018-04-19 |
2019-10-24 |
The Chinese University Of Hong Kong |
Modified nk cells and uses thereof
|
|
GB201807050D0
(en)
*
|
2018-04-30 |
2018-06-13 |
Cellprotect Nordic Pharmaceuticals Ab |
Medical uses
|
|
KR102373502B1
(ko)
|
2018-05-14 |
2022-03-11 |
주식회사 금호에이치티 |
골수유래억제세포 관련 질환의 예방 및 치료 용도
|
|
KR102069704B1
(ko)
*
|
2018-05-16 |
2020-01-23 |
고려대학교 산학협력단 |
Hdac 억제제를 이용한 사람 유래 자연살해세포의 확장 배양법
|
|
US12304962B2
(en)
*
|
2018-05-30 |
2025-05-20 |
Glycostem Therapeutics B.V. |
CAR NK cells
|
|
EP3806894A4
(en)
|
2018-06-12 |
2022-06-08 |
Promab Biotechnologies, Inc. |
PLAP-CAR EFFECTOR CELLS
|
|
CN108815186A
(zh)
*
|
2018-06-14 |
2018-11-16 |
上海鸣大生物科技有限公司 |
一种治疗hpv持续感染引起疾病的药物及制备方法与应用
|
|
WO2020044239A1
(en)
|
2018-08-29 |
2020-03-05 |
National University Of Singapore |
A method to specifically stimulate survival and expansion of genetically-modified immune cells
|
|
CA3112788A1
(en)
|
2018-09-05 |
2020-03-12 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Oncolytic virus platform to treat hematological cancer
|
|
CN112912400B
(zh)
|
2018-10-19 |
2025-05-30 |
明尼苏达大学董事会 |
Nk接合子分子及其使用方法
|
|
EP4578507A3
(en)
|
2018-11-01 |
2025-11-12 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for t cell engineering
|
|
CN113226340A
(zh)
|
2018-11-26 |
2021-08-06 |
恩卡尔塔公司 |
同时扩增多种免疫细胞类型的方法、相关组合物及其在癌症免疫疗法中的用途
|
|
AU2019387571A1
(en)
*
|
2018-11-30 |
2021-06-03 |
Celularity Inc. |
Placenta-derived allogeneic CAR-T cells and uses thereof
|
|
KR20210137085A
(ko)
|
2019-03-05 |
2021-11-17 |
엔카르타, 인크. |
Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
|
|
JP2022525928A
(ja)
*
|
2019-03-21 |
2022-05-20 |
ガミダ セル リミテッド |
併用療法における移植に適したｎｋ細胞画分の増殖及び増殖ｎｋ細胞画分の使用
|
|
JP7711945B2
(ja)
|
2019-04-30 |
2025-07-23 |
センティ バイオサイエンシズ インコーポレイテッド |
キメラ受容体及びその使用方法
|
|
US20220273716A1
(en)
*
|
2019-07-25 |
2022-09-01 |
Celularity Inc. |
Populations of natural killer cells comprising a cd38 chimeric antigen receptor
|
|
EP4022035A4
(en)
*
|
2019-09-01 |
2024-03-27 |
Exuma Biotech Corp. |
Methods and compositions for the modification and delivery of lymphocytes
|
|
CN114828861A
(zh)
*
|
2019-10-10 |
2022-07-29 |
亚利桑那州立大学董事会 |
表达多特异性免疫细胞接合器的溶瘤病毒
|
|
AU2020391511A1
(en)
*
|
2019-11-27 |
2022-06-09 |
Deverra Therapeutics Inc. |
Compositions and methods for culturing hematopoietic stem and progenitor cells
|
|
JP2023504075A
(ja)
*
|
2019-11-28 |
2023-02-01 |
グリコステム セラピューティクス ベスローテン フェンノートシャップ |
Ｃａｒ－ｎｋ細胞を得る方法
|
|
US12685490B2
(en)
|
2020-01-28 |
2026-07-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of preventing or treating pancreatic dysfunction or diabetes by upregulating human cathelicidin LL-37 to inhibit islet amyloid polypeptide (IAPP) self-assembly
|
|
US20230355671A1
(en)
*
|
2020-03-18 |
2023-11-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Upregulation of Cathelicidin Gene Expression as an Adjuvant to Other Treatments for Diseases
|
|
JP2023541694A
(ja)
*
|
2020-09-22 |
2023-10-03 |
ワールド バイオテック リジェネラティブ メディカル グループ リミテッド |
がん治療剤としての二重特異的抗原結合分子を有するｃａｒ発現ナチュラルキラー細胞の生成方法及び組成物
|
|
US11459372B2
(en)
|
2020-11-30 |
2022-10-04 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
EP4271798A1
(en)
|
2020-12-30 |
2023-11-08 |
CRISPR Therapeutics AG |
Compositions and methods for differentiating stem cells into nk cells
|
|
WO2022173737A1
(en)
|
2021-02-09 |
2022-08-18 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for freezing and thawing mammalian cells
|
|
AU2022218710A1
(en)
*
|
2021-02-09 |
2023-08-10 |
Takeda Pharmaceutical Company Limited |
Methods and compositions for freezing and thawing mammalian cells
|
|
CN113398264B
(zh)
*
|
2021-08-06 |
2022-04-29 |
朱有建 |
Nk细胞及其组合物在治疗癌症中的用途
|
|
US20240335472A1
(en)
*
|
2021-08-10 |
2024-10-10 |
Gamida Cell Ltd. |
Anti-her2 car nk cells, methods of their production and uses thereof
|
|
CN113577267B
(zh)
*
|
2021-09-06 |
2022-04-08 |
江西北正干细胞生物科技有限公司 |
Nk细胞和抗体的药物组合物及其在治疗癌症中的用途
|
|
TW202315937A
(zh)
*
|
2021-09-08 |
2023-04-16 |
日商蓋亞生物製藥有限公司 |
細胞之處理方法
|
|
EP4180049A1
(en)
*
|
2021-11-16 |
2023-05-17 |
Ostravska univerzita |
Therapeutic composition for cancer treatment
|
|
CN114058584B
(zh)
*
|
2022-01-07 |
2022-07-01 |
山东省齐鲁干细胞工程有限公司 |
一种临床用自然杀伤细胞的制备方法
|
|
CN115927169B
(zh)
*
|
2022-10-11 |
2023-08-11 |
再造再生医学科技(杭州)有限公司 |
用于扩增cd34+造血干细胞的培养液和体外扩增cd34+造血干细胞的方法
|
|
CN119082021B
(zh)
*
|
2024-09-30 |
2025-03-28 |
广东壹加再生医学研究院有限公司 |
一种增强型nk细胞及其制备方法
|
|
CN119280423A
(zh)
*
|
2024-10-10 |
2025-01-10 |
中南大学 |
一种联合靶向鼻咽癌治疗的载药体系及其制备方法与应用
|
|
CN121426926A
(zh)
*
|
2025-10-21 |
2026-01-30 |
北京京科信拓生物技术有限公司 |
基因编辑的免疫细胞及其应用
|
|
CN121378506A
(zh)
*
|
2025-10-21 |
2026-01-23 |
北京京科信拓生物技术有限公司 |
表达car的免疫细胞及其应用
|